Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Target (CBDY) Liabilities and Shareholders Equity (2016 - 2025)

Target (CBDY) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 18.44% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.6 million through Dec 2025, down 15.02% year-over-year, with the annual reading at $6.2 million for FY2025, 18.44% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $6.2 million at Target, roughly flat from $6.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $13.9 million in Q1 2021, with the low at $6.2 million in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $8.5 million, with a median of $7.7 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity decreased 21.46% in 2023, then fell 5.66% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $13.6 million in 2021, then dropped by 21.93% to $10.6 million in 2022, then decreased by 16.62% to $8.8 million in 2023, then fell by 14.34% to $7.6 million in 2024, then dropped by 18.44% to $6.2 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $6.2 million, $6.2 million, and $6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.